Open Nav
2018 Participating Investors

Below is a representative list of participating investment firms and sell side research analysts for the 2018 BIO Investor Forum.*

AbbVie Ventures
ABES Venture Partners
Abingworth Management
Agent Capital
Agilent Technologies
Alafi Capital Company
Altamont Pharmaceutical Holdings
aMoon Fund
Aquilo Capital
ARCH Venture Partners
Arix Bioscience
Artisan Partners
Asajes Ventures
Aspire Capital Partners
Asset Management Ventures
Astellas Innovation Management
Astellas Venture Management
ATEL Ventures
ATEM Capital
Atheneos Ventures
Athyrium Capital Management
AuGC BioFund LP
Avalon Ventures
Baird Capital
Bay City Capital
Berkeley Catalyst Fund
BGI Venture
Bill and Melinda Gates Foundation Venture Capital
Biomark Capital
BioPacific Investors
Bios Partners
BioSense Global
Biotech Alliances International
BOSON Capital Partners
Brace Pharma Capital
Brain Trust
Brandon Capital Partners
Bridge Bank
Canaan Partners
Canadian Imperial Bank of Commerce
Capital IP
Cato BioVentures
C-Bridge Capital
CDRD Ventures
Cedrus Group
CH Innovations
Codon Capital
Columbia Threadneedle Investments
Core Biotech DMCC
Crosswave Management
CSC Leasing
Data Collective Venture Capital
DEFTA Partners
Dolby Family Ventures
Dorset Capital
Dorset Capital and Par Equity USA
Dynamk Capital
East West Bank
EDB Investments
Efung Capital
Elliott Management
Emerson Collective
ESC Advisors
Excelyrate Capital
Finance Technology Leverage
First Republic Bank
Five Corners Capital
FMG Ventures
Fortress Biotech
Frazier Healthcare Partners
Fusion Fund
GE Ventures
Genesys Capital Partners
Genoa Ventures
GPB Capital
Grey Sky Venture Partners
HealthCare Royalty Partners
Helicase Venture
Hemi Ventures
Horizon Technology Finance
Illumina Accelerator
Illumina Ventures
Innovation Endeavors
Innovation Network Corporation of Japan
IPF Partners
Johnson & Johnson Innovation - JJDC
Johnson & Johnson Innovation Center
Joyance Partners
Julz Co 
Khosla Ventures
Life Science Angels
Lilly Asia Ventures
Lincoln Park Capital

Locust Walk
Longitude Capital
Lyfe Capital
Matthews Asia
Matthews International Capital Management
Maxpro Ventures
MBL Venture Capital Co.
MDX Life Sciences
Medpro Investors
Medstartr Ventures
Merieux Developpement
MidAtlantic Bio Angels
Militia Hill Ventures
Mission Bay Capital
Mitsui & Co. Global Investment
Momentum Biotech
Moore Venture Partners
MP Healthcare Venture Management
MPM Capital
Nan Fung Life Sciences
New Enterprise Associates
New Leaf Venture Partners
Novartis Venture Fund
Novo Ventures
Oceaniq Capital Partners
Olive Tree Capital
Opus Point Partners
OrbiMed Advisors
Oresund Capital
Osage University Partners
OSF Healthcare Ventures
Otsuka Pharmaceutical
Oxford Finance
Palo Alto Investors
Panacea Venture Heathlcare
Pangaea Ventures
Pathway BioVentures
Paulson Investment Company
Pharmstandard Ventures
Pivotal bioVenture Partners
PoC Capital
Premier Partners
Presidio Partners
Prevail Partners
Qiming Venture Partners
Quantum Capital Management
Quark Venture
RBV Capital
Red Tailed Hawk Venture Partners
Relentless Pursuit Partners
Remiges Ventures
Roche Venture Fund
RTP Capital
Salubris Pharma
Samsara BioCapital
Santen Pharmaceutical Co.
Satter Medical Technology Partnership
Silicon Valley Bank SVB
Sofinnova Ventures
Solar Capital
SR One
Startup Sandbox
Surveyor Capital
Syzygy Therapeutics
Taiho Ventures
Taiwania Capital
Terra Magnum Capital Partnership
The Brain Trust Accelerator Fund
The Engine
The Leukemia & Lymphoma Society
Thiel Capital
Tosoh USA
TransPacific Venture Capital Partners
Trinitas Capital
University of Stirling
US Angels
US Global Capital
venBio Partners
Venrock Healthcare Capital Partners
Ventac Partners
Versant Ventures
Viking Global Investors
Vivo Capital
W Global Capital/International Capital Management
WBB Securities
Westlake Ventures
WestPark Capital
WI Harper Group
Xeraya Capital Life Venture
Yonjin Capital
Yuhan USA

*As of 10/16/2018